Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease. Leuzy A, Bollack A, Pellegrino D, Teunissen CE, et al. Alzheimers Dement 2025;21:e14528.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Leuzy A, Bollack A, Pellegrino D, Teunissen CE, et al. Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease. Alzheimers Dement 2025;21:e14528.
PMID: 40042435